
After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related cancer. New research presented at the European Congress on Obesity (ECO) in Malaga, Spain, and published in the journal eClinicalMedicine, suggests that some widely used weight-loss medications may do more than just help people slim [...]